Recruiting Ankylosing Spondylitis Studies in Newark
About Ankylosing Spondylitis Clinical Trials in Newark
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 5 ankylosing spondylitis clinical trials recruiting participants in Newark, OH. These studies are seeking a combined 2,722 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, Merck Sharp & Dohme LLC, AstraZeneca and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Newark — FAQ
Are there ankylosing spondylitis clinical trials in Newark?
Yes, there are 5 ankylosing spondylitis clinical trials currently recruiting in Newark, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Newark?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.
Are clinical trials in Newark free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 5 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated July 13, 2026 from ClinicalTrials.gov